Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Carnegie Clean Energy Limited (CCE)
  6. Company Announcements

Carnegie Clean Energy Limited (ASX: CCE) - Announcements

- Current share price for CCE : $0.051

ASX company news and announcements for Carnegie Clean Energy Limited (CCE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Carnegie Clean Energy Limited (CCE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Carnegie Clean Energy Limited (CCE), please use our Company Announcements tool to search across all ASX-listed companies.

Intelligent Investor free trial for buy hold sell stock recommendations

Latest company announcements for Carnegie Clean Energy Limited (CCE)

Search all Announcements
Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg		 Gain/Loss
$16 Ceasing to be a substantial holder 14 Dec 2016 10:01AM $0.097 $0.051 $0.050 fallen by 47.42%
$16 New Name and Strategy - Avita Medical Limited 6 May 2008 8:23AM $0.012 $0.051 $0.050 risen by 325%
$16 Appendix 4C - quarterly 30 Apr 2008 8:29AM $0.013 $0.051 $0.050 risen by 292.31%
$16 Half Year Report and Accounts 29 Feb 2008 8:26AM $0.016 $0.051 $0.050 risen by 218.75%
$16 MERGER COMPLETION 12 Feb 2008 2:33PM $0.025 $0.051 $0.050 risen by 104%
$16 Appendix 4C - quarterly 30 Jan 2008 8:31AM $0.022 $0.051 $0.050 risen by 131.82%
$16 Appendix 4C - quarterly 30 Oct 2007 8:28AM $0.033 $0.051 $0.050 risen by 54.55%
$16 C3 to merge with Visiomed 10 Oct 2007 9:52AM $0.035 $0.051 $0.050 risen by 45.71%
$16 Trading Halt 9 Oct 2007 9:41AM $0.034 $0.051 $0.050 risen by 50%
$16 Preliminary Final Report 31 Aug 2007 8:28AM $0.038 $0.051 $0.050 risen by 34.21%
$16 Appendix 4C - quarterly 27 Jul 2007 8:29AM $0.036 $0.051 $0.050 risen by 41.67%
$16 Commitments Test Entity - Third Quarter Report 27 Apr 2007 8:33AM $0.045 $0.051 $0.050 risen by 13.33%
$16 Strategic Review 29 Mar 2007 9:29AM $0.061 $0.051 $0.050 fallen by 16.39%
$16 Half Yearly Report/Half Year Accounts 27 Feb 2007 8:27AM $0.074 $0.051 $0.050 fallen by 31.08%
$16 Revised Sales Forecasts 19 Feb 2007 8:26AM $0.090 $0.051 $0.050 fallen by 43.33%
$16 Commitments Test Entity - Second Quarter Report 30 Jan 2007 8:30AM $0.130 $0.051 $0.050 fallen by 60.77%
$16 SPP Oversubscribed & Additional Placement 7 Dec 2006 8:30AM $0.115 $0.051 $0.050 fallen by 55.65%
$16 Update on US approval for ReCell 27 Nov 2006 8:30AM $0.135 $0.051 $0.050 fallen by 62.22%
$16 Response to ASX Query re: Share Price 23 Nov 2006 3:44PM $0.135 $0.051 $0.050 fallen by 62.22%
$16 ReCell Clinical Update 14 Nov 2006 8:30AM $0.092 $0.051 $0.050 fallen by 44.57%
$16 CellSpray approved in Greece 8 Nov 2006 8:29AM $0.085 $0.051 $0.050 fallen by 40%
$16 Commitments Test Entity - First Quarter Report 31 Oct 2006 8:28AM $0.084 $0.051 $0.050 fallen by 39.29%
$16 Underwritten Share Purchase Plan 25 Oct 2006 9:38AM $0.088 $0.051 $0.050 fallen by 42.05%
$16 Supply Agreement 28 Sep 2006 8:30AM $0.097 $0.051 $0.050 fallen by 47.42%
$16 Preliminary Final Report 7 Sep 2006 8:29AM $0.096 $0.051 $0.050 fallen by 46.88%

451 - 475 of 517 results

Page 19 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.